| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-18 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.22 | 2e-06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.2 | 3e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0002 |